<?xml version="1.0" encoding="utf-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd">
	<url>
		<loc>
			http://www.cellulogixintl.com
		</loc>
		<priority>
			0.6
		</priority>
		<changefreq>
			weekly
		</changefreq>
		<lastmod>
			2010-01-02
		</lastmod>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/0308.php?Action=Articles
		</loc>
		<priority>
			0.5
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/0308.php?Action=Links
		</loc>
		<priority>
			0.8
		</priority>
		<changefreq>
			weekly
		</changefreq>
		<lastmod>
			2010-01-02
		</lastmod>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/0308.php?Action=LinksAdd
		</loc>
		<priority>
			0.5
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/0308.php?Action=RelatedLinks
		</loc>
		<priority>
			0.8
		</priority>
		<changefreq>
			weekly
		</changefreq>
		<lastmod>
			2010-01-02
		</lastmod>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/0308.php?Action=Resources
		</loc>
		<priority>
			0.7
		</priority>
		<changefreq>
			weekly
		</changefreq>
		<lastmod>
			2010-01-02
		</lastmod>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/0308.php?Action=Webring
		</loc>
		<priority>
			0.9
		</priority>
		<changefreq>
			weekly
		</changefreq>
		<lastmod>
			2010-01-02
		</lastmod>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/2008/02
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/2008/03
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/2008/04
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/2008/04/page/2
		</loc>
		<priority>
			0.2
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/2008/05
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/2008/06
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/2008/07
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/2008/09
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/2008/11
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/2008/12
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/2008/applicable-conditions/als
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/2008/applicable-conditions/autism
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/2008/applicable-conditions/autoimmune-diseases
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/2008/applicable-conditions/cancer
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/2008/applicable-conditions/cardiovascular-disease
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/2008/applicable-conditions/crohn's-disease
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/2008/applicable-conditions/kidney-diseases
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/2008/applicable-conditions/liver-diseases
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/2008/applicable-conditions/multiple-sclerosis
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/2008/applicable-conditions/preventive-aging
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/2008/applicable-conditions/respiratory-diseases
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/2008/applicable-conditions/spinal-cord-injuries
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/2009/01
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/2009/02
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/2009/02/page/2
		</loc>
		<priority>
			0.2
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/2009/02/page/3
		</loc>
		<priority>
			0.2
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/2009/02/page/4
		</loc>
		<priority>
			0.2
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/2009/02/page/5
		</loc>
		<priority>
			0.2
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/2009/03
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/2009/05
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/2009/06
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/2009/07
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/2009/08
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/2009/11
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/about
		</loc>
		<priority>
			0.5
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/about/founder
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/about/locations
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/about/memberships
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/about/mission-vision
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/about/policy-statement
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/about/staff
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/applicable-conditions/als
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/applicable-conditions/applicable-conditions
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/applicable-conditions/applicable-conditions/als
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/applicable-conditions/applicable-conditions/autism
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/applicable-conditions/applicable-conditions/autoimmune-diseases
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/applicable-conditions/applicable-conditions/cancer
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/applicable-conditions/applicable-conditions/cardiovascular-disease
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/applicable-conditions/applicable-conditions/crohn's-disease
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/applicable-conditions/applicable-conditions/kidney-diseases
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/applicable-conditions/applicable-conditions/liver-diseases
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/applicable-conditions/applicable-conditions/multiple-sclerosis
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/applicable-conditions/applicable-conditions/preventive-aging
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/applicable-conditions/applicable-conditions/respiratory-diseases
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/applicable-conditions/applicable-conditions/spinal-cord-injuries
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/applicable-conditions/autism
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/applicable-conditions/autoimmune-diseases
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/applicable-conditions/cancer
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/applicable-conditions/cardiovascular-disease
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/applicable-conditions/crohn's-disease
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/applicable-conditions/crohns-disease
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/applicable-conditions/diabetes-1-and-2
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/applicable-conditions/kidney-diseases
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/applicable-conditions/liver-diseases
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/applicable-conditions/multiple-sclerosis
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/applicable-conditions/preventive-aging
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/applicable-conditions/recent-study-shows-lack-of-specific-gene-plays-role-in-autism-2
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/applicable-conditions/respiratory-diseases
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/applicable-conditions/spinal-cord-injuries
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/application
		</loc>
		<priority>
			0.5
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/blog
		</loc>
		<priority>
			0.5
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/blog/adult-stem-cells/apheresislp
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/blog/adult-stem-cells/cellulogix-biosciences
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/blog/adult-stem-cells/cellulogix-international
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/blog/adult-stem-cells/cellulogix-international/comment-page-1
		</loc>
		<priority>
			0.2
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/blog/adult-stem-cells/global-opportunities
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/blog/adult-stem-cells/global-opportunities/comment-page-1
		</loc>
		<priority>
			0.2
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/blog/adult-stem-cells/letter-from-a-patients-physical-therapist
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/blog/adult-stem-cells/new-international-clinic-opening
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/blog/adult-stem-cells/rebuttal
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/blog/adult-stem-cells/what-are-stem-cells
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/blog/biotechnology/patient-testimonial
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/blog/page/2
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/company-news/a-very-heartfelt-thank-you
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/company-news/european-center-now-open
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/company-news/letter-from-the-president
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/company-news/lumbar-puncture-procedure-for-spinal-cord-injuries-and-neurological-disorders
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/company-news/new-clinics-coming-soon
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/company-news/new-global-treatment-centers
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/company-news/new-procedure-apheresis
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/company-news/press-release-december-2-2008
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/company-news/stem-cell-treatment-in-zona-rio-mexico
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/contact-us
		</loc>
		<priority>
			0.5
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/disclaimer
		</loc>
		<priority>
			0.5
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/faq
		</loc>
		<priority>
			0.5
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/home
		</loc>
		<priority>
			0.5
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/news
		</loc>
		<priority>
			0.5
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/news/company-news
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/news/company-news/page/2
		</loc>
		<priority>
			0.2
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/news/photo-gallery
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/news/stem-cell-update
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/news/stem-cell-update/page/2
		</loc>
		<priority>
			0.2
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/news/stem-cell-update/page/3
		</loc>
		<priority>
			0.2
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/news/video-gallery
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/our-services
		</loc>
		<priority>
			0.5
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/our-services/advantages
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/our-services/for-physicians
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/our-services/our-programs
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/our-services/patents
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/our-services/sponsors
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/stem-cell-update/2020-a-new-vision-a-future-for-regenerative-medicine
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/stem-cell-update/amazing-recovery-attributed-to-cord-blood
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/stem-cell-update/apheresis
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/stem-cell-update/apheresis/comment-page-1
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/stem-cell-update/canadian-led-research-team-grows-early-stage-heart-cells-from-stem-cells
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/stem-cell-update/early-research-suggests-umbilical-cord-blood-cell-therapy-may-reduce-progression-of-alzheimers-disease
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/stem-cell-update/fda-to-take-key-step-in-stem-cell-research
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/stem-cell-update/financing-available
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/stem-cell-update/financing-available/comment-page-1
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/stem-cell-update/heart-derived-stem-cells-develop-into-heart-muscle
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/stem-cell-update/human-stem-cells-provide-a-new-model-for-lou-gehrigs-disease
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/stem-cell-update/interview-with-european-health-magazine
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/stem-cell-update/new-clinics-on-the-horizon
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/stem-cell-update/new-lumbar-puncture-procedure
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/stem-cell-update/new-research-reveals-nerve-cells-made-from-new-cell-stem-cell
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/stem-cell-update/opening-soon
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/stem-cell-update/patent-filings
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/stem-cell-update/preventive-aging
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/stem-cell-update/recent-study-shows-lack-of-specific-gene-plays-role-in-autism-3
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/stem-cell-update/scientists-make-human-cow-embryos
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/stem-cell-update/scientists-produce-stem-cells-from-ordinary-mouse-skin-cells
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/stem-cell-update/stem-cell-research-leads-to-potential-new-therapy-for-rare-blood-disorder
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/stem-cell-update/stem-cell-scaffolds-could-repair-damage-of-strokes
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/stem-cell-update/stem-cells-discovered-in-human-breast-milk-2
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/stem-cell-update/stem-cells-from-hair-follicles-may-help-grow-new-blood-vessels
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/stem-cell-update/stem-cells-offer-cartilage-repair-hope-for-arthritis-sufferers
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/stem-cells
		</loc>
		<priority>
			0.5
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/stem-cells/apheresis
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/stem-cells/applicable-conditions
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/stem-cells/applicable-conditions/als
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/stem-cells/applicable-conditions/autism
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/stem-cells/applicable-conditions/autoimmune-diseases
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/stem-cells/applicable-conditions/cancer
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/stem-cells/applicable-conditions/cardiovascular-disease
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/stem-cells/applicable-conditions/crohn's-disease
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/stem-cells/applicable-conditions/kidney-diseases
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/stem-cells/applicable-conditions/liver-diseases
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/stem-cells/applicable-conditions/multiple-sclerosis
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/stem-cells/applicable-conditions/preventive-aging
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/stem-cells/applicable-conditions/respiratory-diseases
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/stem-cells/applicable-conditions/spinal-cord-injuries
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/stem-cells/specific-lines
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/stem-cells/what-are-stem-cells
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/testimonials
		</loc>
		<priority>
			0.5
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/testimonials/117
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/testimonials/andrew-m
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/testimonials/bennie-f
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/testimonials/bobby-p
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/testimonials/bonnie-r
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/testimonials/brian-b
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/testimonials/corrine-f
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/testimonials/david-c
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/testimonials/dean-k
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/testimonials/debbie-h
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/testimonials/frank-o
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/testimonials/glenn-g
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/testimonials/howard-b
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/testimonials/howard-w
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/testimonials/jeannine-r
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/testimonials/jeff-k
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/testimonials/joanne-l
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/testimonials/john-j
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/testimonials/lillian-c
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/testimonials/lorraine-m
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/testimonials/martha-l
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/testimonials/martin-c
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/testimonials/nelson-o
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/testimonials/page/2
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/testimonials/page/3
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/testimonials/patty-a
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/testimonials/richard-s
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/testimonials/rosalie-c
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/testimonials/stephanie-c
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/testimonials/wendy-k
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/testimonials/william-d
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/testimonials/william-d-2
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/uncategorized/home-landing-page
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/uncategorized/mission-vision
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/uncategorized/personal-letter-from-dr-nabavi
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/uncategorized/personal-letter-from-dr-nabavi/comment-page-1
		</loc>
		<priority>
			0.3
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/video-gallery/connie-p-testimonial
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/video-gallery/frank-o-primary-lateral-sclerosis-treatment-date-11108
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/video-gallery/jeannine-r-copd-patient-treatment-date-41507
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/video-gallery/lillian-c-copd-patient-treatment-date-52207
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/video-gallery/lumbar-puncture-patients
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/video-gallery/vance-k-testimonial
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/video-gallery/wayne-c-testimonial
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/video-gallery/wendy-k-ms-patient-treatment-date-31507
		</loc>
		<priority>
			0.4
		</priority>
		<changefreq>
			weekly
		</changefreq>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/wp-login.php
		</loc>
		<priority>
			0.5
		</priority>
		<changefreq>
			weekly
		</changefreq>
		<lastmod>
			2010-01-02
		</lastmod>
	</url>
	<url>
		<loc>
			http://www.cellulogixintl.com/wp-login.php?action=lostpassword
		</loc>
		<priority>
			0.5
		</priority>
		<changefreq>
			weekly
		</changefreq>
		<lastmod>
			2010-01-02
		</lastmod>
	</url>
</urlset>
<!-- cache-time: 86400  -->
